Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean dextrosa and potassium chloride and sodium chloride?
Displaying drugs 14226 - 14250 of 14598 in total

E-6005

E6005 has been used in trials studying the treatment of Atopic Dermatitis.
Investigational

MRX-I

MRX-I has been used in trials studying the treatment of Bacterial Infections.
Investigational

NLX-P101

NLX-P101, gene therapy is developed by Neurologix to treat Parkinson’s disease. The gene is glutamic acid decarboxylase (GAD), whose product synthesizes the major inhibitory neurotransmitter in the brain, (gamma)-aminobutyric acid (GABA), and targets the subthalamic nucleus (STN), which is overactive in patients with Parkinson’s disease. NLX-P101 is being evaluated as...
Investigational
Matched Description: … product synthesizes the major inhibitory neurotransmitter in the brain, (gamma)-aminobutyric acid (GABA), and …

Alphamethadol

Experimental
Illicit

(2Z)-2-(Benzoylamino)-3-[4-(2-bromophenoxy)phenyl]acrylic acid

Experimental

4-Flourobenzenesulfonamide

Experimental

AL5424

Experimental

3-Amino-4-Oxybenzyl-2-Butanone

Experimental

Phenylacetaldehyde

Experimental

AL7089A

Experimental

N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide

Experimental

Undecyl-Phosphinic Acid Butyl Ester

Experimental

Benzylamine

Experimental

4-(Hydroxymethyl)Benzamidine

Experimental

1,3-Dinitrobenzene

Experimental

3-Nitrophenylboronic Acid

Experimental

Para-Bromobenzyl Alcohol

Experimental

DAS869

Experimental

3-(4-Benzenesulfonyl-Thiophene-2-Sulfonylamino)-Phenylboronic Acid

Experimental

4-Fluorobenzylamine

Experimental

2,6-Difluorobenzenesulfonamide

Experimental

1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea

Experimental

3-Iodo-Benzyl Alcohol

Experimental

N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide

Experimental

4-(trifluoromethyl)phenol

Experimental
Displaying drugs 14226 - 14250 of 14598 in total